|
業務類別
|
Biotechnology |
|
業務概覽
|
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908. |
| 公司地址
| 4600 South Syracuse Street, Suite 900, Denver, CO, USA, 80237 |
| 電話號碼
| +1 858 704-4900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.palisadebio.com |
| 員工數量
| 14 |
| Dr. Mitchell Lawrence Jones, M.D.,PhD |
President and Chief Medical Officer |
美元 440.00K |
29/04/2026 |
| Mr. J. D. Finley |
Director, Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer |
美元 575.00K |
29/04/2026 |
|
|
| Mr. Robert F. Baltera, Jr |
Independent Director |
29/04/2026 |
| Mr. Donald A. Williams |
Chairman of the Board |
29/04/2026 |
| Mr. J. D. Finley |
Director, Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer |
29/04/2026 |
| Mr. Binxian Wei |
Independent Director |
29/04/2026 |
| Dr. Emil Chuang, B.S.,F.R.A.C.P.,M.B. |
Independent Director |
29/04/2026 |
|
|
|
|
